Conflict of Interest Disclosures: Dr Geng reported receiving research support from Pfizer that was paid directly to her institution and receiving personal fees from UnitedHealth Group. Dr Erlandson reported receiving grants from Gilead Sciences paid to directly to her institution and receiving personal fees from Gilead Sciences, ViiV, and Merck. Dr Brown reported receiving personal fees from Breas Medical. Dr Castro reported receiving grants from ALA, AstraZeneca, GSK, Novartis, Pulmatrix, Sanofi-Aventis, Shionogi, Teva, Gala Therapeutics, Theravance, Nocion, and Genentech and receiving personal fees from Allakos, Amgen, Apogee, Apreo Health, Arrowhead Pharmaceuticals, Blueprint Medicines, Connect Biopharma, Evommune, Jasper, Kinaset, Merck, Novartis, OM Pharma, Pfizer, Pioneering Medicines, Sanofi-Aventis, Teva, Third Rock Ventures, Upstream Bio, Verona Pharmaceuticals, and Aer Therapeutics. Dr Deeks reported receiving personal fees from BioVie Pharma, Enanta, and Pfizer and receiving nonfinancial support from Aerium, Eli Lilly, and Gilead. Dr Erdmann reported receiving personal fees from Pfizer and having a patent for human neutralizing antibodies that was licensed to PlantForm. Dr Ghamloush reported receiving grants from 4DMedical. Dr Goepfert reported having a patent for COVID-19 monoclonal antibody that was licensed to Aridis Pharmaceuticals. Dr Goldman reported having research contracts with Gilead, Regeneron, and Helix; receiving grants from Gilead and BARDA (Merck); serving as a speaker or advisory board member for Gilead, Merck, and Invivyd; and having collaborative service agreements with Adaptive Biotechnologies and Monogram Biosciences/Labcorp. Dr Hess reported receiving personal fees from Astellas Pharmaceuticals. Dr Hirshberg reported receiving grants from Intermountain Health. Dr Krishnan reported receiving grants from the Patient-Centered Outcomes Research Institute, the COPD Foundation, the American Lung Association, and Verily that were paid directly to his institution. Dr Levitan reported receiving research support from Amgen that was paid directly to her institution and receiving personal fees from the University of Pittsburgh. Dr Marconi reported receiving research support and consultation fees from Eli Lilly, Bayer, Gilead Sciences, Merck, and ViiV that were paid directly to his institution. Dr Metz reported receiving grants from Pfizer. Dr Novak reported receiving personal fees from Gilead and Moderna. Dr Parthasarathy reported receiving grants from Verily Lifesciences, Philips, and Regeneron that were paid directly to his institution and receiving personal fees from AbbVie, Apria Healthcare, and Jazz Pharmaceuticals. Dr Peluso reported receiving research support from Aerium Therapeutics that was paid directly to his institution; receiving personal fees from Gilead Sciences, AstraZeneca, BioNTech, BioVie, and Apellis Pharmaceuticals; and receiving nonfinancial support from Aerium Therapeutics and Shionogi. Dr Verduzco-Gutierrez reported receiving research support from Ipsen that was paid directly to her institution and receiving personal fees from Ipsen, AbbVie, Merz, Revance, and Pfizer. Dr Wisnivesky reported receiving personal fees from Sanofi, ThermoFisher Scientific/PPD, Banook, the American Medical Association, and BioNTech and receiving grants from Sanofi, Regeneron, and Axella. Dr McComsey reported receiving research support from Astellas, Roche, Genentech, Pfizer, Redhill, and Cognivue and receiving personal fees from GSK/ViiV, Gilead, Janssen, and Merck. No other disclosures were reported.
PubMed
